Chi G, Yee MK, Amin AN. , et al.
Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the APEX trial (Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban Trial).
137 (01) 91-94
Download Bibliographical Data